A master cancer gene hijacks a ‘molecular crowbar’ to make breast cancer cells invasive January 22, 2021
The price of a drug should be based on its therapeutic benefits – not just what the market will bear January 19, 2021
A master cancer gene hijacks a ‘molecular crowbar’ to make breast cancer cells invasive January 22, 2021
The price of a drug should be based on its therapeutic benefits – not just what the market will bear January 19, 2021
Conferences ASCO 2020: Trastuzumab combined with trimodality treatment does not improve outcomes for patient June 1, 2020 Results of the NRG Oncology clinical trial RTOG 1010 indicated that the addition of the…